Net Income

With its AI-powered blood test nearing FDA review, DELFI Diagnostics adds a top biotech CFO to its board, signaling major commercial and IPO ambitions.

Once a student finding refuge at Milton Hershey School, Maria Trinh Kraus now chairs its boards, shaping the very legacy that transformed her own life.

A new partnership brings a single-dose treatment for common, serious infections to Sub-Saharan Africa, a region with high prevalence and unmet medical needs.

A new partnership makes Petco Park a leader in sustainability, diverting over 2,000 tons of waste from landfills through a revolutionary composting system.

A Calgary startup's revolutionary wound care gel, already used in hospitals, is now being funded by the government for battlefield trauma applications.

An alumnus's $1M gift lets Rutgers students manage a real portfolio. In a volatile market, their disciplined strategy is already beating Wall Street benchmarks.

Facing soaring edtech costs, districts are now building custom AI tools, saving money and creating solutions that are perfectly tailored to educator needs.

A new survey reveals security teams see less than half of AI tools built by employees, creating a massive, unmanaged attack surface inside organizations.

A financially struggling healthcare firm makes a bold leap into neurotechnology, but can it compete with giants like Neuralink in the high-risk BCI race?

Once a promising EV startup, Bollinger Motors has collapsed. Its complete manufacturing assets and new trucks are now up for auction in a cautionary tale.

Swiss medtech vVARDIS secures a major Apollo investment, valuing it over $1B for its revolutionary non-invasive cavity treatment, Curodont™.

RedHill Biopharma flips a capital deficit to positive equity, driven by savvy partnerships for its drugs Talicia and Bekinda and a promising R&D pipeline.

After four failed challenges from Microsoft, a small US firm's touchscreen patent case reaches China's highest court, setting the stage for a landmark ruling.

As TLS certificate lifespans shrink, a new tool from GMO GlobalSign aims to automate security for small businesses, preventing costly outages and cyber risks.

In a key human trial, Sona Nanotech's heat-based therapy saw a 60% complete response in tumors for melanoma patients who had exhausted other options.

A landmark study reveals essential phospholipids significantly reduce liver fat and fatigue in MASLD patients, offering a new tool against a silent epidemic.

Amid performance issues, non-prime lender goeasy is nominating three new directors and launching a six-point recovery plan, earning a crucial nod from ISS.

GWM unveils its GWM ONE platform, a radical modular system for all powertrains, and a bold ethical stance to navigate a turbulent global market.

As Weibo prepares its Q1 2026 results, investors are watching closely. Can its AI pivot overcome user decline, fierce competition, and new ad regulations?

As Vietnam eyes a 2050 net-zero target, a Canadian firm's technology offers its massive diesel fleet an immediate path to fuel savings and lower emissions.